The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians

BMC Genetics

Volumn 2, Issue , 2001, Pages

  Chiu, Ken C ^a   Chuang, Lee Ming ^b   Yoon, Carol ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; GLUCOSE; INSULIN; LIPID; THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL MODEL; BODY MASS; CAUCASIAN; CELL FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS ISLET BETA CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SAMPLE SIZE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 2942617344     PISSN: 14712156     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2156-2-7     Document Type: Article

References (40)

1. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990, 6:1-27
2. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH: A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991, 90:229-235
3. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinbum B, Esposito-Del Puente A, et al: Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989, 38:1423-1432
4. Bogardus C, Lillioja S, Ward R, Degregorio M, Mott D, Ferraro R, et al: Association and linkage between insulin resistance and MNS red cell antigens in Pima Indians. Diabetes 1991, 40(S1):297A-
5. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, et al: Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993, 42:514-519
6. Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, i:785-789
7. Randle PJ: Carbohydrate metabolism and lipid storage and breakdown in diabetes. Diabetologia 1966, 2:237-247
8. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ, Gordon JI: Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem 1987, 262:5931-5937
9. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995, 95:1281-1287
10. Permutt MA, Chiu KC, Ferrer J, Glaser B, Inoue H, Nestorowicz A, et al: Genetics of type II diabetes. Recent Prog Horm Res 1998, 53:201-216
11. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Jearvinen H: Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997, 30:1144-1149
12. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357
13. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B: Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996, 81:4334-4337
14. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, et al: Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997, 40:706-710
15. Mitchell BD, Kammerer CM, O'Connell P, Harrison CR, Manire M, Shipman P, et al: Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 1995, 44:1046-1053
16. Lepraetre F, Vionnet N, Budhan S, Dina C, Powell KL, Gaenin E, et al: Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery. Diabetes Metab 1998, 24:244-250
17. Clement K, Dina C, Basdevant A, Chastang N, Pelloux V, Lahlou N, et al: A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q. Diabetes 1999, 48:398-402
18. Stem MP, Mitchell BD, Blangero J, Reinhart L, Krammerer CM, Harrison CR, et al: Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 1996, 45:563-568
19. Vionnet N, Hani EH, Lesage S, Philippi A, Hager J, Varret M, et al: Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes 1997, 46:1062-1068
20. Vigouroux C, Khallouf E, Bourut C, Robert JJ, de Kerdanet M, Tubiana-Rufi N, et al: Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J Clin Endocrinol Metab 1997, 82:3438-3444
21. Humphreys P, McCarthy M, Tuomilehto J, Tuomilehto-Wolf E, Stratton I, Morgan R, et al: Chromosome 4q locus associated with insulin resistance in Pima Indians. Studies in three European NIDDM populations. Diabetes 1994, 43:800-804
22. Yagi T, Nishi S, Hinata S, Murakami M, Yoshimi T: A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects. Diabet Med 1996, 13:902-907
23. Ito K, Nakatani K, Fujii M, Katsuki A, Tsuchihashi K, Murata K, et al: Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabet Med 1999, 16:119-124
24. Hayakawa T, Nagai Y, Nohara E, Yamashita H, Takamura T, Abe T, et al: Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism 1999, 48:655-657
25. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL: Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999, 48:1868-1872
26. Mandelcom R, Connelly PW, Boright A, Young TK, Hegele RA: F5 Q506 mutation and the low prevalence of cardiovascular disease in Canadian Inuit. J Investig Med 1998, 46:232-235
27. Saarinen L, Pulkkinen A, Kareinen A, Heikkinen S, Lehto S, Laakso M: Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM. Diabetes Care 1998, 21:849-850
28. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B: Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997, 17:1060-1066
29. Pihiajameaki J, Rissanen J, Heikkinen S, Karjalainen L, Laakso M: Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1997, 17:1039-1044
30. Boullu-Sanchis S, Lepraetre F, Hedelin G, Donnet JP, Schaffer P, Froguel P, et al: Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab 1999, 25:150-156
31. Rissanen J, Pihiajameaki J, Heikkinen S, Kekealeainen P, Kuusisto J, Laakso M: The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes 1997, 46:711-712
32. Vidgren HM, Sipileainen RH, Heikkinen S, Laakso M, Uusitupa MI: Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 1997, 27:405-408
33. Sipileainen R, Uusitupa M, Heikkinen S, Rissanen A, Laakso M: Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997, 82:2629-2632
34. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993, 92:91-98
35. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M: Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998, 18:1606-1610
36. Hegele RA, Wolever TM, Story JA, Connelly PW, Jenkins DJ: Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 1997, 27:857-862
37. Chiu KC, McCarthy JE: The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 1997, 46:395-399
38. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192
39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419
40. Chiu KC, Province MA, Permutt MA: Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes 1992, 41:843-849